Literature DB >> 27543889

Development of ovarian cancer after excision of endometrioma.

Hirofumi Haraguchi1, Kaori Koga2, Masashi Takamura1, Tomoko Makabe1, Fusako Sue1, Mariko Miyashita1, Yoko Urata1, Gentaro Izumi1, Miyuki Harada1, Tetsuya Hirata1, Yasushi Hirota1, Osamu Wada-Hiraike1, Katsutoshi Oda1, Kei Kawana1, Tomoyuki Fujii1, Yutaka Osuga1.   

Abstract

OBJECTIVE: To determine the prevalence rate of subsequent development of ovarian cancer after excision of endometrioma.
DESIGN: Retrospective cross-sectional study.
SETTING: University hospital. PATIENT(S): A total of 485 women with endometrioma. INTERVENTION(S): Excisions of endometrioma were performed between 1995 and 2004. Data were collected from medical records in 2013. MAIN OUTCOME MEASURE(S): Age, revised American Society for Reproductive Medicine score, cyst diameter, follow-up periods, endometrioma recurrence, and development of ovarian cancer. RESULT(S): Recurrence of endometrioma was recorded in 121 patients (24.9% of the entire cohort), and 4 patients (0.8% of the entire cohort) developed ovarian cancer. All ovarian cancers developed from a recurrent endometrioma (3.3% of patients who experienced recurrence). Recurrence of endometrioma was significantly associated with ovarian cancer development. CONCLUSION(S): Ovarian cancers can develop after excision of endometrioma and are more likely to arise from recurrent endometrioma. Special care such as rigorous follow-up should be practiced to manage patients who experience recurrence of endometrioma.
Copyright © 2016 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; cystectomy; endometriosis; ovary

Mesh:

Year:  2016        PMID: 27543889     DOI: 10.1016/j.fertnstert.2016.07.1077

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  6 in total

Review 1.  Endometriosis-associated ovarian cancer occurs early during follow-up of endometrial cysts.

Authors:  Kosuke Murakami; Yasushi Kotani; Reona Shiro; Hisamitsu Takaya; Hidekatsu Nakai; Noriomi Matsumura
Journal:  Int J Clin Oncol       Date:  2019-08-31       Impact factor: 3.402

2.  Long-term Health Consequences of Endometriosis - Pathways and Mediation by Treatment.

Authors:  Leslie V Farland; Holly R Harris
Journal:  Curr Obstet Gynecol Rep       Date:  2020-05-29

3.  Endometriosis-Associated Ovarian Cancer: The Origin and Targeted Therapy.

Authors:  Kosuke Murakami; Yasushi Kotani; Hidekatsu Nakai; Noriomi Matsumura
Journal:  Cancers (Basel)       Date:  2020-06-24       Impact factor: 6.639

4.  Subsequent Development of Epithelial Ovarian Cancer After Ovarian Surgery for Benign Ovarian Tumor: A Population-Based Cohort Study.

Authors:  Chen-Yu Huang; Wen-Hsun Chang; Hsin-Yi Huang; Chao-Yu Guo; Yiing-Jenq Chou; Nicole Huang; Wen-Ling Lee; Peng-Hui Wang
Journal:  Clin Epidemiol       Date:  2020-06-18       Impact factor: 4.790

5.  Contralateral ovarian endometrioma recurrence after unilateral salpingo-oophorectomy.

Authors:  Tokie Hidari; Tetsuya Hirata; Tomoko Arakawa; Kaori Koga; Kazuaki Neriishi; Shinya Fukuda; Akari Nakazawa; Natsuki Nagashima; Suke Ma; Hui Sun; Masashi Takamura; Miyuki Harada; Yasushi Hirota; Osamu Wada-Hiraike; Tomoyuki Fujii; Yutaka Osuga
Journal:  BMC Womens Health       Date:  2019-05-02       Impact factor: 2.809

6.  Comparing Paclitaxel-Carboplatin with Paclitaxel-Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer.

Authors:  Chen-Yu Huang; Min Cheng; Na-Rong Lee; Hsin-Yi Huang; Wen-Ling Lee; Wen-Hsun Chang; Peng-Hui Wang
Journal:  Int J Environ Res Public Health       Date:  2020-03-26       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.